41. Giant cell arteritis Clinical trials / Disease details
Clinical trials : 128 / Drugs : 139 - (DrugBank : 36) / Drug target genes : 33 - Drug target pathways : 124
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2020-001019-26-NL (EUCTR) | 26/02/2021 | 14/07/2020 | Imaging of inflamed arteries in giant cell arteritis with a PET/CT scan. | [18F]fluor-PEG-folate PET/CT imaging in Giant Cell Arteritis. | giant cell arteritis;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] | Product Name: [18F]PEG-Folate INN or Proposed INN: Fluorine-18 Other descriptive name: FLUORINE-18 | University Medical Center Groningen, Department of Rheumatology and Clinical Immunology | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 10 | Phase 2 | Netherlands |